These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1942933)

  • 1. [Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study].
    Hassel JU; Brämswig JH; Schlegel W; Schellong G
    Klin Padiatr; 1991; 203(4):268-72. PubMed ID: 1942933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
    Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
    Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
    Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G
    Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
    Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
    Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
    An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.
    Dörffel W; Lüders H; Rühl U; Albrecht M; Marciniak H; Parwaresch R; Pötter R; Schellong G; Schwarze EW; Wickmann L
    Klin Padiatr; 2003; 215(3):139-45. PubMed ID: 12838937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85].
    Schellong G; Hörnig I; Brämswig J; Bökkerink JP; Steinhoff A; Ludwig R; Niethammer D; Reiter A; von Lengerke HJ; Heinecke H
    Klin Padiatr; 1988; 200(3):205-13. PubMed ID: 3062257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
    Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
    Schellong G; Pötter R; Brämswig J; Wagner W; Prott FJ; Dörffel W; Körholz D; Mann G; Rath B; Reiter A; Weissbach G; Riepenhausen M; Thiemann M; Schwarze EW
    J Clin Oncol; 1999 Dec; 17(12):3736-44. PubMed ID: 10577845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal function in young patients successfully treated for Hodgkin disease.
    Papadakis V; Vlachopapadopoulou E; Van Syckle K; Ganshaw L; Kalmanti M; Tan C; Sklar C
    Med Pediatr Oncol; 1999 May; 32(5):366-72. PubMed ID: 10219339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study.
    Charak BS; Gupta R; Mandrekar P; Sheth NA; Banavali SD; Saikia TK; Gopal R; Dinshaw KA; Advani SH
    Cancer; 1990 May; 65(9):1903-6. PubMed ID: 2115396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Kreissl S; Sökler M; Hellmuth JC; Meissner J; Mathas S; Topp MS; Behringer K; Klapper W; Kuhnert G; Dietlein M; Kobe C; Fuchs M; Diehl V; Engert A; Borchmann P
    Lancet Oncol; 2017 Dec; 18(12):1680-1687. PubMed ID: 29133014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
    Heikens J; Behrendt H; Adriaanse R; Berghout A
    Cancer; 1996 Nov; 78(9):2020-4. PubMed ID: 8909325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group.
    Schellong G; Brämswig JH; Hörnig-Franz I; Schwarze EW; Pötter R; Wannenmacher M
    Ann Oncol; 1994; 5 Suppl 2():113-5. PubMed ID: 8204510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group.
    Schellong G
    Baillieres Clin Haematol; 1996 Sep; 9(3):619-34. PubMed ID: 8922249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.
    Al-Tonbary Y; Sarhan MM; El-Ashry RA; Salama E; Sedki M; Fouda A
    Leuk Lymphoma; 2010 Apr; 51(4):656-63. PubMed ID: 20218813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.